0001950047-24-000716.txt : 20240207 0001950047-24-000716.hdr.sgml : 20240207 20240207161841 ACCESSION NUMBER: 0001950047-24-000716 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240207 DATE AS OF CHANGE: 20240207 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc. CENTRAL INDEX KEY: 0001710072 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821725586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40236 FILM NUMBER: 24604591 BUSINESS ADDRESS: STREET 1: 1715 38TH ST CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-262-7002 MAIL ADDRESS: STREET 1: 1715 38TH ST CITY: BOULDER STATE: CO ZIP: 80301 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: MOORE JOHN R CENTRAL INDEX KEY: 0001191702 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 3200 WALNUT ST CITY: BOULDER STATE: CO ZIP: 80301 144 1 primary_doc.xml 144 0001191702 XXXXXXXX LIVE 0001710072 EDGEWISE THERAPEUTICS INC 001-40236 1715 38th Street Boulder CO 80301 720-262-7002 JOHN R MOORE Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Fl. New York NY 10004

29835 585661.05 63461608 02/07/2024 NASDAQ Common 02/07/2024 Exercise of Stock Options Issuer N 29835 02/07/2024 Cash N 10b5-1 Sales for JOHN R MOORE

1715 38th Street Boulder CO 80301

Common 12/27/2023 8497 89218.50 The securities to be sold were and will be received upon the exercise of stock options over the next three months. 02/07/2024 06/30/2023 /s/ John R Moore